Found in:
Notebook
News of the Wierd
The Spectator
Raleigh NC
http://www.spectatoronline.com
SYNERGY!
In October, the pharmaceutical division of Japan Tobacco,
the world's third-largest cigarette company, bought the rights
to lung cancer vaccines now under development by the U.S. firms
Cell Genesys abd Coryxa. Now under one roof are the cause,
treatment and potential prevention of lung cancer.
To Unsubscribe: Email majordomo@ces.ncsu.edu with the command
"unsubscribe sanet-mg". If you receive the digest format, use the command
"unsubscribe sanet-mg-digest".
To Subscribe to Digest: Email majordomo@ces.ncsu.edu with the command
"subscribe sanet-mg-digest".
All messages to sanet-mg are archived at:
http://www.sare.org/htdocs/hypermail